Cisplatin Pfizer Dosage & Drug Information

Concise Prescribing Info

Contents

Cisplatin

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Indications/Uses

Monotherapy or in combination w/ other chemotherapeutic agents for metastatic non-seminomatous germ cell carcinoma, advanced stage refractory ovarian/bladder carcinoma, refractory squamous cell carcinoma of the head & neck.

Dosage/Direction for Use

IV Adult & childn Monotherapy: 50-100 mg/m² as single infusion every 3-4 wk over 6-8 hr or slow infusion of 15-20 mg/m² daily for 5 days every 3-4 wk. Combination therapy w/ the following cytotoxic agents: Testicular cancer Vinblastine, bleomycin, actinomycin D. Ovarian cancer Cyclophosphamide, doxorubicin, hexamethylmelamine, 5-fluorouracil. Head & neck cancer Bleomycin, MTX.

Contraindications

History of hypersensitivity to cisplatin or platinum-containing compd. Hearing disorders. Bone marrow depression. Generalised infections. Renal impairment. Pregnancy & lactation.

MIMS Class

Cytotoxic Chemotherapy

ATC Classification

L01XA01 - cisplatin ; Belongs to the class of platinum-containing antineoplastic agents. Used in the treatment of cancer.

Regulatory Classification

POM

Presentation/Packing

Form

Cisplatin Pfizer inj 1 mg/mL

Packing/Price

1's

Cisplatin Pfizer

cisplatin

Manufacturer:

Bridgewest Perth Pharma